In vivo imaging of human and mouse skin with a handheld dual-axis confocal fluorescence microscope.

Advancing molecular therapies for the treatment of skin diseases will require the development of new tools that can reveal spatiotemporal changes in the microanatomy of the skin and associate these changes with the presence of the therapeutic agent. For this purpose, we evaluated a handheld dual-axis confocal (DAC) microscope that is capable of in vivo fluorescence imaging of skin, using both mouse models and human skin. Individual keratinocytes in the epidermis were observed in three-dimensional image stacks after topical administration of near-infrared (NIR) dyes as contrast agents. This suggested that the DAC microscope may have utility in assessing the clinical effects of a small interfering RNA (siRNA)-based therapeutic (TD101) that targets the causative mutation in pachyonychia congenita (PC) patients. The data indicated that (1) formulated indocyanine green (ICG) readily penetrated hyperkeratotic PC skin and normal callused regions compared with nonaffected areas, and (2) TD101-treated PC skin revealed changes in tissue morphology, consistent with reversion to nonaffected skin compared with vehicle-treated skin. In addition, siRNA was conjugated to NIR dye and shown to penetrate through the stratum corneum barrier when topically applied to mouse skin. These results suggest that in vivo confocal microscopy may provide an informative clinical end point to evaluate the efficacy of experimental molecular therapeutics.

[1]  Eva M. Sevick-Muraca,et al.  Single-Dose Intravenous Toxicity Study of IRDye 800CW in Sprague-Dawley Rats , 2010, Molecular Imaging and Biology.

[2]  W. Piyawattanametha,et al.  Two-Dimensional MEMS Scanner for Dual-Axes Confocal Microscopy , 2007, Journal of Microelectromechanical Systems.

[3]  D. Leake,et al.  Single-nucleotide-specific siRNA targeting in a dominant-negative skin model. , 2008, The Journal of investigative dermatology.

[4]  W. Piyawattanametha,et al.  3-D Near-Infrared Fluorescence Imaging Using an MEMS-Based Miniature Dual-Axis Confocal Microscope , 2009, IEEE Journal of Selected Topics in Quantum Electronics.

[5]  R. Hickerson,et al.  First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  D. Leake,et al.  Development of therapeutic siRNAs for pachyonychia congenita. , 2008, The Journal of investigative dermatology.

[7]  Christopher H Contag,et al.  Three-dimensional in vivo imaging by a handheld dual-axes confocal microscope. , 2008, Optics express.

[8]  E. Lane,et al.  Intermediate filaments in disease. , 1995, Current opinion in cell biology.

[9]  D. Leake,et al.  Silencing of reporter gene expression in skin using siRNAs and expression of plasmid DNA delivered by a soluble protrusion array device (PAD). , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  G. Kino,et al.  siRNA silencing of keratinocyte-specific GFP expression in a transgenic mouse skin model , 2009, Gene Therapy.

[11]  Thomas D. Wang,et al.  Dual-axis confocal microscope for high-resolution in vivo imaging. , 2003, Optics letters.

[12]  E. Lane,et al.  Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenita. , 2008, Journal of dermatological science.

[13]  S. Nakae,et al.  Therapeutic silencing of an endogenous gene by siRNA cream in an arthritis model mouse , 2009, Gene Therapy.

[14]  Christopher H Contag,et al.  Assessing delivery and quantifying efficacy of small interfering ribonucleic acid therapeutics in the skin using a dual-axis confocal microscope. , 2010, Journal of biomedical optics.

[15]  E. Lane,et al.  Clinical and pathological features of pachyonychia congenita. , 2005, The journal of investigative dermatology. Symposium proceedings.

[16]  D. Leake,et al.  Development of quantitative molecular clinical end points for siRNA clinical trials. , 2011, The Journal of investigative dermatology.

[17]  C. Contag,et al.  Increased interstitial pressure improves nucleic acid delivery to skin enabling a comparative analysis of constitutive promoters , 2010, Gene Therapy.

[18]  P. White,et al.  C-5 propyne-modified oligonucleotides penetrate the epidermis in psoriatic and not normal human skin after topical application. , 2002, The Journal of investigative dermatology.

[19]  S. Leachman,et al.  The genetic basis of pachyonychia congenita. , 2005, The journal of investigative dermatology. Symposium proceedings.